Search

Your search keyword '"Lonn E"' showing total 412 results

Search Constraints

Start Over You searched for: Author "Lonn E" Remove constraint Author: "Lonn E"
412 results on '"Lonn E"'

Search Results

51. Ezetimibe added to statin therapy after acute coronary syndromes

53. Women with stable coronary artery disease have better clinical outcomes than men, but this association is modified by degree of depression : insights from the STABILITY trial

54. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

55. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals

56. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals

58. P858Women with stable coronary artery disease have better clinical outcomes than men, but this association is modified by degree of depression: insights from the STABILITY trial

59. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

60. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

61. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

62. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

63. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

65. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

66. Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk

67. Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics

68. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals

69. Ramipril reduces cardiovascular events in high-risk, older women. (Abstracts: a digest of recent research in geriatric care)

70. Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies

71. Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes

72. Pathophysiologic and therapeutic importance of tissue ACE: a consensus report

73. Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])

74. The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: Analysis protocol and baseline characteristics

78. Venous thromboembolism in association with features of the metabolic syndrome

83. The relevance of tissue angiotensin-converting enzyme: manifestations inmechanistic and endpoint data.

84. Reply

89. Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/ TRANSCEND studies.

90. Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies.

91. Revision of the three Boraginaceae genera Echiochilon, Ogastemma and Sericostoma

98. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data.

Catalog

Books, media, physical & digital resources